BioCentury
ARTICLE | Company News

Scancell, Merck KGaA deal

January 17, 2005 8:00 AM UTC

MRK's Biovation Ltd. subsidiary (Aberdeen, U.K.) will use its DeImmunisation technology on up to two additional antibodies from Scancell. The deal includes Scancell's SC101 antibody against Lewis y/b,...